Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $164.02 | 14 | 55.2% |
| Education | $133.37 | 3 | 44.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $117.46 | 11 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $105.69 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $34.37 | 2 | $0 (2020) |
| SANOFI PASTEUR INC. | $23.16 | 1 | $0 (2019) |
| Novocure Inc. | $16.71 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $34.37 | 2 | E.R. Squibb & Sons, L.L.C. ($34.37) |
| 2019 | $140.62 | 12 | Janssen Biotech, Inc. ($117.46) |
| 2018 | $16.71 | 1 | Novocure Inc. ($16.71) |
| 2017 | $105.69 | 2 | Pharmacyclics LLC, An AbbVie Company ($105.69) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/27/2020 | E.R. Squibb & Sons, L.L.C. | INREBIC (Drug) | Education | Cash or cash equivalent | $19.42 | General |
| Category: Hematology | ||||||
| 07/27/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $14.95 | General |
| Category: Oncology | ||||||
| 12/19/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: Oncology | ||||||
| 11/21/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Oncology | ||||||
| 10/07/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), FLUZONE QUADRIVALENT, FLUBLOK QUADRIVALENT | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: VACCINES | ||||||
| 06/26/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Oncology | ||||||
| 06/20/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Oncology | ||||||
| 06/06/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Oncology | ||||||
| 05/15/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Oncology | ||||||
| 03/20/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Oncology | ||||||
| 02/21/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: Oncology | ||||||
| 01/17/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Oncology | ||||||
| 10/17/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Optune | ||||||
| 12/21/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 11/16/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 1,003 | 1,558 | $194,332 | $106,681 |
| 2020 | 5 | 896 | 1,488 | $185,510 | $92,896 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 587 | 1,096 | $140,357 | $78,841 | 56.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 217 | 234 | $19,422 | $11,271 | 58.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 62 | 90 | $10,530 | $5,019 | 47.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $6,996 | $3,554 | 50.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $6,164 | $3,351 | 54.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $2,775 | $1,854 | 66.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $1,950 | $914.81 | 46.9% |
| 38221 | Biopsy of bone marrow | Office | 2021 | 15 | 15 | $2,715 | $889.65 | 32.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 19 | 19 | $2,223 | $515.61 | 23.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 20 | $1,200 | $470.21 | 39.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 618 | 1,189 | $151,997 | $76,614 | 50.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 144 | 158 | $13,119 | $6,571 | 50.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 26 | 26 | $6,968 | $3,381 | 48.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $5,088 | $2,647 | 52.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 33 | 38 | $4,933 | $2,396 | 48.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 40 | 42 | $2,492 | $901.86 | 36.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 11 | 11 | $913.00 | $384.55 | 42.1% |
About Dr. Michael Deleo, M.D
Dr. Michael Deleo, M.D is a Hematology & Oncology healthcare provider based in Pittsfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447222443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Deleo, M.D has received a total of $297.39 in payments from pharmaceutical and medical device companies, with $34.37 received in 2020. These payments were reported across 17 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($164.02).
As a Medicare-enrolled provider, Deleo has provided services to 1,899 Medicare beneficiaries, totaling 3,046 services with total Medicare billing of $199,578. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Pittsfield, MA
- Active Since 02/03/2006
- Last Updated 09/26/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447222443
Products in Payments
- Imbruvica (Drug) $105.69
- DARZALEX (Biological) $65.72
- Erleada (Drug) $51.74
- FLUZONE HIGH-DOSE (Drug) $23.16
- INREBIC (Drug) $19.42
- Oncology (Device) $16.71
- OPDIVO (Biological) $14.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Pittsfield
Harvey Zimbler, M.d, M.D
Hematology & Oncology — Payments: $3,096
Spyridon Triantos, M.d, M.D
Hematology & Oncology — Payments: $90.69
Paul Rosenthal, M.d, M.D
Hematology & Oncology — Payments: $41.85
Jesse Spector, M.d, M.D
Hematology & Oncology